대한부인종양학회

최신 논문

총 게시글 : 136

Advances in Vulvar Cancer: A Radiation Oncology Perspective 2025-09-26 VIEW : 3
Vaginal Adenocarcinoma: A Review of a Rare Gynecologic Cancer 2025-09-26 VIEW : 2
Vulvar and vaginal cancer during pregnancy: A pooled analysis of 15 cases from the International Network on Cancer, Infertility and Pregnancy and review of the literature 2025-09-26 VIEW : 2
Targeted therapies in primary vaginal cancer 2025-09-26 VIEW : 3
Robotic-assisted versus conventional laparoscopic surgery for endometrial cancer: long-term results of a randomized controlled trial. 2025-06-23 VIEW : 47
First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial. 2025-06-23 VIEW : 15
Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of Chemoradiation Versus Chemotherapy for Locally Advanced Endometrial Carcinoma. 2025-06-23 VIEW : 12
Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial. 2025-06-23 VIEW : 9
A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: An NRG oncology/GOG study. 2025-06-23 VIEW : 5
Neo-adjuvant pembrolizumab in stage IV high-grade serous ovarian cancer: the phase II Neo-Pembro trial 2025-06-23 VIEW : 16
Patient-reported outcomes from the MIRASOL trial evaluating mirvetuximab soravtansine versus chemotherapy in patients with folate receptor α-positive, platinum-resistant ovarian cancer: a randomised, open-label, phase 3 trial 2025-06-23 VIEW : 9
Bevacizumab, Atezolizumab, and Acetylsalicylic Acid in Recurrent, Platinum-Resistant Ovarian Cancer: The EORTC 1508-GCG Phase II Study 2025-06-23 VIEW : 4
Risk factors for anastomotic leakage and its impact on survival outcomes in radical multivisceral surgery for advanced ovarian cancer: an AGO-OVAR.OP3/LION exploratory analysis 2025-06-23 VIEW : 14
The efficacy and safety of mirvetuximab soravtansine in FRα-positive, third-line and later, recurrent platinum-sensitive ovarian cancer: the single-arm phase II PICCOLO trial 2025-06-23 VIEW : 7
SUCCOR 10 years: a decade’s perspective on radical hysterectomy outcomes in cervical cancer 2025-06-23 VIEW : 13

1
2
3
4
5
6
7
8
9
10